Industry: Pharmaceuticals, Biotechnology
Ecopia is finding novel anticancer therapies from soil-dwelling microorganisms that are one of the most prolific sources of drugs. Our current focus is to move our flagship compound ECO-4601 through Phase I clinical trials. ECO-4601 is a novel small molecule that, based on advanced animal models, crosses the blood brain barrier and is effective in significantly inhibiting primary brain tumor growth and other types of cancers. Just like well-known chemotherapies such as doxorubicin and mitomycin C, ECO-4601 comes from microorganisms that live in common soil. However, unlike these drugs that were discovered many decades ago, ECO-4601 represents a new chemical class that is derived from Ecopia’s proprietary drug discovery platform ( www.ecopiabio.com )
Ecopia BioSciences Inc.
7290 Frederick Banting
Saint-Laurent, Quebec H4S 2A1
Canada
Tel: (514) 336-2700
Fax: (514) 336-8827